|
Rep spoke with the patient before the trial to discuss her leg weakness, heaviness, and difficulty walking.The placement proceeded as planned, and the patient was fine in the pacu.During conversation, patient reported experiencing relief.However, due to the ongoing weakness in her leg, the surgeon decided to conclude the trial.Rep has no additional information, and the device was explanted.
|
|
Section d references the main component of the system.Other medical products in use during the event include: brand name specify surescan; product id 977c265 (serial: (b)(6); product type: 0200-lead; implant date (b)(6) 2026; explant date medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|